Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
This study is currently recruiting participants.
Verified February 2011
by Groupe Oncologie Radiotherapie Tete et Cou
Study NCT01289522 Information provided by Groupe Oncologie Radiotherapie Tete et Cou
First Received on February 1, 2011. Last Updated on February 2, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Recurrent or Metastatic Disease
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Squamous Cell
Head and Neck Neoplasms
Neoplasm Metastasis
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
cetuximab IV
Biopsies
Additional drug interventions recognized in this trial
Antineoplastic Agents
Cetuximab
Cisplatin
Docetaxel
More general drug interventions related to this trial
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Groupe Oncologie Radiotherapie Tete et Cou
Institut Gustave Roussy
Back to top of Main Content